Cannabis can be used as a psychedelic in therapy, but it’s not for everyone, some mental health providers say

Psychedelic therapy is an emerging field that offers hope to many Canadians suffering from mental illness. While substances like psilocybin and MDMA are commonly used in this type of therapy, some are turning to cannabis as an alternative. Under the supervision of a trained therapist, patients use drugs that alter their consciousness in an attempt to treat hard-to-treat conditions.

Vancouver registered psychologist Hillary McBride, who hosts the CBC podcast Other People’s Problems, believes that cannabis can be a useful tool in therapy. One advantage of using cannabis is that it is easier to access than other psychedelics due to its legal status in Canada. Patients can discuss drug interactions and health risks with their doctors, making it a more familiar option for many.

McBride’s podcast exclusively focuses on psychedelic psychotherapy sessions, with the majority utilizing cannabis. Through the podcast, listeners can gain insight into what these therapy sessions sound like, helping to demystify the process. However, therapists and researchers caution that this approach is not suitable for everyone and that research in this area is still in its early stages.

Research on the psychedelic effects of cannabis is limited compared to other psychedelics. Dr. David Wolinsky, an addiction psychiatrist, conducted a literature review on the subject and found promising potential for further research. While the use of cannabis in psychotherapy is less known, some therapists believe it can have utility similar to other psychedelics when administered correctly.

Psychedelic assisted therapy sessions may not look much different from regular therapy sessions, but there are strict protocols in place to ensure the safety and well-being of patients. Conversations about consent, safety, and readiness are essential, and additional healthcare providers may be present during sessions.

Dr. Jennifer Swainson, a psychiatrist from the University of Alberta, advises against the use of cannabis in psychotherapy, particularly for those with mood or anxiety disorders. She warns that cannabis can be a risk factor for the development of mental health conditions, especially in young people whose brains are still developing.

While cannabis therapy has shown positive outcomes for some patients, it is not suitable for everyone. McBride emphasizes the importance of thoughtful consideration before engaging in this type of therapy, as there are risks involved. Establishing trust between the patient and the healthcare provider is crucial for successful outcomes in psychedelic therapy.

Overall, the use of cannabis in psychedelic therapy shows promise but requires further research and caution. Patients should seek guidance from trained professionals and should not attempt this type of therapy on their own. With careful consideration and proper supervision, cannabis therapy could be a valuable tool in the treatment of mental health conditions.